A systematic review of stakeholder perceptions of supervised injection facilities

Bardwell, 2017, Assessing support for supervised injection services among community stakeholders in London, Canada, Int. J. Drug Policy, 48, 27, 10.1016/j.drugpo.2017.05.009 Barry, 2018 Bayoumi, 2012 Booth, 2016, Searching for qualitative research for inclusion in systematic reviews: a structured methodological review, Syst. Rev., 5 Bozinoff, 2017, Still “at risk”: an examination of how street-involved young people understand, experience, and engage with “harm reduction” in Vancouver’s inner city, Int. J. Drug Policy, 45, 33, 10.1016/j.drugpo.2017.05.006 Braun, 2006, Using thematic analysis in psychology, Qual. Res. Psychol., 3, 77, 10.1191/1478088706qp063oa Burstein, 2003, The impact of public opinion on public policy: a review and an agenda, Polit. Res. Q., 56, 29, 10.1177/106591290305600103 Butler, 2018, Attitudes of intravenous drug users in London towards the provision of drug consumption rooms, Drugs Educ. Prev. Policy, 25, 31, 10.1080/09687637.2016.1252316 Chen, 2009, Health consequences of illegal drug use, Curr. Opin. Psychiatry, 22, 287, 10.1097/YCO.0b013e32832a2349 Ciccarone, 2017, Fentanyl in the US heroin supply: a rapidly changing risk environment, Int. J. Drug Policy, 46, 107, 10.1016/j.drugpo.2017.06.010 Critical Appraisal Skills Programme, 2017 Davidson, 2018, Using drugs in un/safe spaces: impact of perceived illegality on an underground supervised injecting facility in the United States, Int. J. Drug Policy, 53, 37, 10.1016/j.drugpo.2017.12.005 Dwyer, 2016, Public injecting and public amenity in an inner-city suburb of Melbourne, Australia, J. Subst. Use, 21, 162 Fairbairn, 2008, Seeking refuge from violence in street-based drug scenes: women’s experiences in North America’s first supervised injection facility, Soc. Sci. Med., 67, 817, 10.1016/j.socscimed.2008.05.012 Fairbairn, 2010, Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study, Harm Reduct. J., 7 Fast, 2008, The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility, Harm Reduct. J., 5 Frost, 2017 Fry, 2002, Injecting drug user attitudes towards rules for supervised injecting rooms: implications for uptake, Int. J. Drug Policy, 13, 471, 10.1016/S0955-3959(02)00076-2 Fry, 1999, Establishing safe injecting rooms in Australia: attitudes of injecting drug users, Aust. N. Z. J. Public Health, 23, 501, 10.1111/j.1467-842X.1999.tb01306.x Gardner, 2017 Green, 2002 Hammarberg, 2016, Qualitative research methods: when to use them and how to judge them, Hum. Reprod., 31, 498, 10.1093/humrep/dev334 Harris, 2018, Perceptions about supervised injection facilities among people who inject drugs in Philadelphia, Int. J. Drug Policy, 52, 56, 10.1016/j.drugpo.2017.11.005 Hedrich, 2010 Hudson, 2009 Hyshka, 2013, Prospects for scaling‐up supervised injection facilities in Canada: the role of evidence in legal and political decision‐making, Addiction, 108, 468, 10.1111/add.12064 Joffe, 2004, Content and thematic analysis, Research Methods for Clinical and Health Psychology Jozaghi, 2012, “A little heaven in hell”: The role of a supervised injection facility in transforming place, Urban Geogr., 33, 1144, 10.2747/0272-3638.33.8.1144 Jozaghi, 2013, Should North America’s first and only supervised injection facility (InSite) be expanded in British Columbia, canada?, Harm Reduct. J., 10, 10.1186/1477-7517-10-1 Jozaghi, 2014, A case study of the transformative effect of peer injection drug users in the Downtown Eastside of Vancouver, Canada, Can. J. Criminol. Crim. Justice, 56, 563, 10.3138/CJCCJ.2013.E30 Jozaghi, 2018, Activism and scientific research: 20 years of community action by the Vancouver area network of drug users, Subst. Abuse Treat. Prev. Policy, 13 Katz, 2017, Support of supervised injection facilities by emergency physicians in Canada, Int. J. Drug Policy, 49, 26, 10.1016/j.drugpo.2017.07.013 Kennedy, 2017, Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review, Curr. HIVAIDS Rep., 14, 161, 10.1007/s11904-017-0363-y Kerr, 2004, Harm-reduction activism: a case study of an unsanctioned user-run safe injection site, Can. HIV Policy Law Rev., 9, 13 Kerr, 2007, A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver’s safer injection facility, Int. J. Drug Policy, 18, 37, 10.1016/j.drugpo.2006.12.008 Kerr, 2017 Kimber, 2007, Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia, J. Urban Health, 84, 255, 10.1007/s11524-006-9145-3 Kolla, 2017, Risk creating and risk reducing: community perceptions of supervised consumption facilities for illicit drug use, Health Risk Soc., 19, 91, 10.1080/13698575.2017.1291918 KPMG, 2010 Krüsi, 2009, An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation, AIDS Care, 21, 638, 10.1080/09540120802385645 Malowaniec, 2000 Malowaniec, 2003 McColloch, 2017 McNeil, 2014, ‘Safer environment interventions’: a qualitative synthesis of the experiences and perceptions of people who inject drugs, Soc. Sci. Med., 106, 151, 10.1016/j.socscimed.2014.01.051 McNeil, 2014, “People knew they could come here to get help”: an ethnographic study of assisted injection practices at a peer-run ‘unsanctioned’ supervised drug consumption room in a Canadian setting, AIDS Behav., 18, 473, 10.1007/s10461-013-0540-y Meade, 1997, Selecting and appraising studies for a systematic review, Ann. Intern. Med., 127, 531, 10.7326/0003-4819-127-7-199710010-00005 MSIC Evaluation Committee, 2003 O’Shea, 2007, Introducing safer injecting facilities (SIFs) in the Republic of Ireland: ‘chipping away’ at policy change, Drugs Educ. Prev. Policy, 14, 75, 10.1080/09687630600911684 Olsen, 2007 Pabayo, 2013, The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting, Drug Alcohol Depend., 132, 603, 10.1016/j.drugalcdep.2013.04.007 Philbin, 2009, Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico, Int. J. Drug Policy, 20, 329, 10.1016/j.drugpo.2008.09.002 Potier, 2014, Supervised injection services: what has been demonstrated? A systematic literature review, Drug Alcohol Depend., 145, 48, 10.1016/j.drugalcdep.2014.10.012 Pro Sentret, 2001 Rance, 2011, Accidental intimacy: transformative emotion and the Sydney medically supervised injecting centre, Contemp. Drug Probl., 38, 121, 10.1177/009145091103800106 Rautenberg, 2013 Rudd, 2016, Increases in drug and opioid overdose deaths—united States, 2000–2014, Am. J. Transplant., 16, 1323, 10.1111/ajt.13776 Skretting, 2009 Small, 2008, Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study, Drug Alcohol Depend., 98, 159, 10.1016/j.drugalcdep.2008.05.014 Small, 2009, Access to health and social services for IDU: the impact of a medically supervised injection facility, Drug Alcohol Rev., 28, 341, 10.1111/j.1465-3362.2009.00025.x Small, 2011, IDU perspectives on the design and operation of North America’s first medically supervised injection facility, Subst. Use Misuse, 46, 561, 10.3109/10826084.2010.517714 Small, 2011, Injection drug users’ access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture, Qual. Health Res., 21, 743, 10.1177/1049732311400919 Small, 2012, Perceptions of risk and safety within injection settings: injection drug users’ reasons for attending a supervised injecting facility in Vancouver, Canada, Health Risk Soc., 14, 307, 10.1080/13698575.2012.680950 Strike, 2015, Ambivalence about supervised injection facilities among community stakeholders, Harm Reduct. J., 12 Thomas, 2008, Methods for the thematic synthesis of qualitative research in systematic reviews, BMC Med. Res. Methodol., 8 Watson, 2012, Police perceptions of supervised consumption sites (SCSs): a qualitative study, Subst. Use Misuse, 47, 364, 10.3109/10826084.2011.645104 Watson, 2015, “Drugs don’t have age limits”: the challenge of setting age restrictions for supervised injection facilities, Drugs Educ. Prev. Policy, 22, 370, 10.3109/09687637.2015.1034239 Wenger, 2011, The prospect of implementing a safer Injection Facility in San Francisco: perspectives of community stakeholders, Int. J. Drug Policy, 22, 239, 10.1016/j.drugpo.2011.01.001 Whiteford, 2013, Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010, Lancet, 382, 1575, 10.1016/S0140-6736(13)61611-6 Whiteford, 2015, The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010, PLoS One, 10, 10.1371/journal.pone.0116820 Zampini, 2014, Governance versus government: drug consumption rooms in Australia and the UK, Int. J. Drug Policy, 25, 978, 10.1016/j.drugpo.2014.03.006